2.9(top 20%)
impact factor
3.2K(top 10%)
papers
74.0K(top 5%)
citations
102(top 5%)
h-index
3.0(top 20%)
impact factor
4.0K
all documents
77.1K
doc citations
151(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1TGF-β signaling and epithelial–mesenchymal transition in cancer progressionCurrent Opinion in Oncology2013698
2Histone deacetylase inhibitors as new cancer drugsCurrent Opinion in Oncology2001482
3Oncogenic PI3K and its role in cancerCurrent Opinion in Oncology2006454
4Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistanceCurrent Opinion in Oncology1995422
5Heat shock protein 90Current Opinion in Oncology2003365
6Telomerase activity in human cancerCurrent Opinion in Oncology1996335
7Multidrug resistance transporters and modulationCurrent Opinion in Oncology2000333
8Mechanisms of apoptosis avoidance in cancerCurrent Opinion in Oncology1999312
9Multiple roles of the tumor suppressor p53Current Opinion in Oncology2002301
10Glucose transporters in cancer metabolismCurrent Opinion in Oncology2012288
11Sarcomas of the head and neck regionCurrent Opinion in Oncology2003263
12p21WAF1 and tumourigenesisCurrent Opinion in Oncology2013255
13Recent changes in the epidemiology of head and neck cancerCurrent Opinion in Oncology2009251
14Human papillomavirus–associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancersCurrent Opinion in Oncology2001248
15Radiation-induced and chemotherapy-induced pulmonary injuryCurrent Opinion in Oncology2001240
16New molecular insights into osteosarcoma targeted therapyCurrent Opinion in Oncology2013240
17The management of brain edema in brain tumorsCurrent Opinion in Oncology2004239
18Doctor-patient communication and satisfaction with care in oncologyCurrent Opinion in Oncology2005237
19Biobanking: the foundation of personalized medicineCurrent Opinion in Oncology2011236
20Epidermal growth factor receptor biology (IMC-C225)Current Opinion in Oncology2001225
21Microsatellite instability in inherited and sporadic neoplasmsCurrent Opinion in Oncology1995221
22Use of rituximab, the new FDA-approved antibodyCurrent Opinion in Oncology1998215
23The MAPK pathway in melanomaCurrent Opinion in Oncology2008215
24MucositisCurrent Opinion in Oncology2015213
25Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodiesCurrent Opinion in Oncology2016213
26Current status of interleukin-10 and regulatory T-cells in cancerCurrent Opinion in Oncology2013211
27Regulation of Bcl-xL: a little bit of this and a little bit of STATCurrent Opinion in Oncology2000210
28Aneuploidy and cancerCurrent Opinion in Oncology2000210
29Targeting the hallmarks of cancerCurrent Opinion in Oncology2013209
30The changing epidemiology of thyroid cancerCurrent Opinion in Oncology2015209
31Clinical and molecular approaches to well differentiated and dedifferentiated liposarcomaCurrent Opinion in Oncology2011203
32Update on neurological paraneoplastic syndromesCurrent Opinion in Oncology2015192
33Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the futureCurrent Opinion in Oncology2008191
34Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcomaCurrent Opinion in Oncology2007190
35Surgery of low-grade gliomas: towards a ‘functional neurooncology’Current Opinion in Oncology2009187
36Ba/F3 cells and their use in kinase drug discoveryCurrent Opinion in Oncology2007185
37Tumor-cell-derived microvesicles as carriers of molecular information in cancerCurrent Opinion in Oncology2013185
38Molecular pathogenesis of malignant gliomasCurrent Opinion in Oncology1999184
39Different mechanisms in the tumorigenesis of proximal and distal colon cancersCurrent Opinion in Oncology2001182
40Cancer therapy and p53Current Opinion in Oncology1995180
41Targeting EZH2 in cancer therapyCurrent Opinion in Oncology2017179
42Primary and metastatic diseases in malignant melanoma of the gastrointestinal tractCurrent Opinion in Oncology2000172
43Patient-physician communication in oncology: past, present, and futureCurrent Opinion in Oncology2005171
44Interferons: mechanisms of action and clinical applicationsCurrent Opinion in Oncology2003166
45Epidemiology of head and neck cancers: an updateCurrent Opinion in Oncology2020166
46The role of beta-catenin in cell adhesion, signal transduction, and cancerCurrent Opinion in Oncology1998164
47The Warburg effect in 2012Current Opinion in Oncology2012164
48Duel nature of TGF-?? signaling: tumor suppressor vs. tumor promoterCurrent Opinion in Oncology2005161
49Carney complex: the first 20 yearsCurrent Opinion in Oncology2007161
50STAT proteins as novel targets for cancer therapyCurrent Opinion in Oncology1999160